Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response (Q36804367)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2007

Language	Label	Description	Also known as
English	Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response	scientific article published on January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response (English)

1 reference

Europe PubMed Central

16 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

Alessandro Colasanti

object named as

Alessandro Colasanti

3

0 references

author name string

Massimo C Mauri

1

1 reference

Europe PubMed Central

16 August 2017

Lucia S Volonteri

2

1 reference

Europe PubMed Central

16 August 2017

Alessio Fiorentini

4

1 reference

Europe PubMed Central

16 August 2017

Ilaria F De Gaspari

5

1 reference

Europe PubMed Central

16 August 2017

Silvio R Bareggi

6

1 reference

Europe PubMed Central

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

16 August 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

16 August 2017

46

1 reference

Europe PubMed Central

16 August 2017

359-388

1 reference

Europe PubMed Central

16 August 2017

5

1 reference

Europe PubMed Central

16 August 2017

https://scigraph.springernature.com/pub.10.2165/00003088-200746050-00001

0 references

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Influence of patient-related variables on clozapine plasma levels.

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200746050-00001

21 January 2018

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone metabolism, aldehyde oxidase, and clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine: a basic science update.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Will routine therapeutic drug monitoring have a place in clozapine therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone plasma levels, clinical response and side-effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comments on the role of therapeutic drug monitoring for clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 and therapeutic drug monitoring with respect to clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome and olanzapine plasma levels in acute schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma amisulpride levels in schizophrenia or schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of risperidone in humans: a summary

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine: a review of its use in the management of bipolar I disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of clozapine in chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of QT interval in isolated feline hearts by antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of aripiprazole and concomitant lithium and valproate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone dose and blood level variability: accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of quetiapine: an atypical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute effect of sertindole on brain 5-HT2, D2 and ?1 receptors (ex vivo radioreceptor binding studies)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentrations and clinical effects of risperidone in schizophrenic patients in Singapore--a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine : A Review of its Use in Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comprehensive psychopathological rating scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of long-acting injectable risperidone at steady-state: comparison with oral administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and therapeutics of acute intramuscular ziprasidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Concentrations and Side Effects in Psychiatric Patients During Risperidone Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Displacement of one drug by another from carrier or receptor sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical profile of risperidone, a new antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the efficacy, tolerability and safety of sertindole in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological profile of risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinemia after low dose of amisulpride.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple-dose pharmacokinetics of clozapine in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine: new research on efficacy and mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine plasma level monitoring: current status

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, metabolism, and excretion of risperidone in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertindole and dopamine D 2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123 I-IBZM SPECT study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone: the fifth atypical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical use of plasma clozapine levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spotlight on ziprasidone in schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of plasma ziprasidone using liquid chromatography with fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine metabolism rate as a possible index of drug-induced granulocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug metabolism and atypical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone versus haloperidol in long-term hospitalized chronic patients in a double blind randomized trial: a post hoc analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of sertindole: identification of the metabolites in the rat and dog, and species comparison of liver microsomal metabolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simplified ultraviolet liquid chromatographic method for determination of sertindole, dehydrosertindole and norsertindole, in human plasma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between effects and plasma levels of clozapine (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of clinical outcome in schizophrenic patients responding to clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential olanzapine plasma concentrations by sex in a fixed-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biotransformation of Post-Clozapine Antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The computerized continuous performance test

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine treatment of schizophrenic patients. Plasma concentration and coagulation factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and drug interactions: update for new antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition and biotransformation of the antipsychotic agent olanzapine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine monitoring: plasma or serum levels?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17465637

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200746050-00001

1 reference

Europe PubMed Central

16 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36804367&oldid=1656712329"